Novo Nordisk A/S (0TDD)
LSE • 0TDD • US6701002056
ORTEX Data Highlights
ORTEX Data Highlights
As of Oct 28, 2026, ORTEX estimated 0% of free float sold short, 94.5 days to cover, cost to borrow 0.37%. Sign up for live short interest data.
Market Cap
180b USD | # 96 in GB
Volume
103.7k shares | 513.59m USD
Shares Outstanding
3.35t
Free Float Shares
94.66% | 3.17t
